Journals / Akademik Gıda / 2013 / Cilt: 11 - Sayı: 2

Production of Pudding Mix Containing Dried Blueberries Vaccinium corymbosum L. for Phenylketonuria Patients

Fenilketonüri Hastaları İçin Maviyemiş Vaccinium corymbosum L. İçeren Toz Puding Karışımı Üretimi

Pages
28–36
Publication Date
2013-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The formulation containing 15% CMP isolate and 15% dried blueberries was chosen as the best formulation according to the results of sensory evaluation and viscosity analysis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, pudding mix containing dried blueberry Vaccinium corymbosum L. and caseinomacropeptide CMP was developed for phenylketonuria patients.
📊
Key Findings & Data:The percentage of CMP in the lyophilized isolate was 57.56 ± 0.18%.
💡
Conclusion & Impact:The formulation containing 15% CMP isolate and 15% dried blueberries was chosen as the best formulation according to the results of sensory evaluation and viscosity analysis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kazeinomakropeptit KMP · Fenilalanin · Tirozin

Abstract

In this study, pudding mix containing dried blueberry Vaccinium corymbosum L. and caseinomacropeptide CMP was developed for phenylketonuria patients. CMP, having no phenylalanine Phe in its amino acid sequence, was isolated from sweet whey as a protein source. The percentage of CMP in the lyophilized isolate was 57.56 ± 0.18%. The yield of CMP was 71.22 ± 0.21%. Six different pudding mixes were prepared by the addition of different proportions of CMP isolate 10, 12 or 15% and different amounts of dried blueberries 10 or 15% . The formulation containing 15% CMP isolate and 15% dried blueberries was chosen as the best formulation according to the results of sensory evaluation and viscosity analysis. Phenylalanine and tyrosine Tyr contents of pudding mix and cooked pudding were 134.05 mg Phe/100 g, 478.73 mg Tyr/100 g and 32.39 mg Phe/100 g, 106.41 mg Tyr/ 100 g, respectively

Özet

Bu çalışmada, fenilketonüri hastaları için kazeinomakropeptit KMP ve kurutulmuş maviyemiş Vaccinium corymbosum L. içeren toz puding karışımı geliştirilmiştir. Bu amaçla, amino asit diziliminde fenilalanin Phe bulunmayan kazeinomakropeptit KMP , peynir altı suyundan izole edilerek protein kaynağı olarak kullanılmıştır. Elde edilen liyofilize izolattaki KMP oranı %57.56±0.18 olarak bulunmuştur. KMP verimi ise %71.22±0.21 olarak hesaplanmıştır. Farklı oranlarda %10, 12 veya 15 KMP izolatı ve kurutulmuş maviyemiş %10 veya 15 içeren altı farklı toz puding karışımından duyusal özellikler ve viskozite açısından en uygun formülasyonun %15 KMP izolatı ve %15 kurutulmuş maviyemiş içeren puding olduğu belirlenmiştir. Toz karışım ve pişmiş pudingin Phe ve tirozin Tyr içerikleri sırasıyla 134.05mg Phe/100 g, 478.73 mg Tyr/100 g ve 32.39 mg Phe/100 g, 106.41 mg Tyr/ 100 g olarak saptanmıştır

🔖

Cite This Article

ERGÜL, N., KARAKAYA, S. (2013). Production of Pudding Mix Containing Dried Blueberries Vaccinium corymbosum L. for Phenylketonuria Patients. Akademik Gıda, Cilt: 11 - Sayı: 2, 28–36. https://ajindex.com/articles/454775

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Seçkin, Y., 2007. Fenilketonürili çocukların psikopedagojik sorunları ve çözümleri. IX. Uluslararası Katılımlı Beslenme ve Metabolizma Kongresi, İstanbul, 39-43
  2. Waisbren, S.S., Noel, K., Fahrbach, K., Cella, C., Frame, D., Dorenbaum, A., Levy, H., 2007. Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta analysis. Molecular Genetics and Metabolism 92: 63-70
  3. Linder, M.C., 1991. Nutrition and Metabolism of Proteins, In Nutritional Biochemistry and Metabolism, M.C., 2nd ed., Appleton and Lange, Norwalk, Connecticut., 105p
  4. National Institutes of Health (NIH), 2000. Phenylketonuria (PKU): Screening and Management. NIH Consensus Statement, 17, 1– 33p. 5] Özer, E.A., Banoğlu, Ş., Banoğlu, E., 2008. Fenilketonüri hastalığı ve fenilalanin kısıtlı diyet. Türkiye 10. Gıda Kongresi, Erzurum, 1139
  5. Proņina, N., Lugovska, R., 2011. Association between minihaplotypes and mutations at the phenylalanine hydroxylase locus in Latvian phenylketonuria patients. Proceedings of the Latvian Academy of Sciences, Section B 65 (3/4): 73–79
  6. Williams, R.A., Mamotte, C.D.S., Burnett, J.R., 2008. Phenylketonuria: an inborn error of phenylalanine metabolism Clin. Biochem. 29: 31– 41
  7. Ney, D.M., Gleason, S.T., Calcar, SC., MacLeod, E.L., Nelson, K.L., Etzel M.R., Rice, G.M., Wolff, J.A., 2009. Nutritional management of PKU with glycomacropeptide from cheese whey. Journal Inherit Metabolic Disease 32: 32–39
  8. Acosta, P., Yanicelli, S., 2001. The Ross metabolic formula system nutrition support protocols, 4th ed., Columbus, Ohio: Ross Laboratories, Ross Product Division, 1-32
  9. Weetch, E., MacDonald, A., 2006. The determination of phenylalanine content of foods suitable for phenylketonuria. J. Hum Nutr Dietetic. 19:229–236
  10. Altunsu, T., 2007, Ulusal yenidoğan tarama programı, IX. Uluslararası Katılımlı Beslenme ve Metabolizma Kongresi, İstanbul,123-125. [12] http://www.pkuvesiz.com/mevzuat_ve_uygulamalar. asp (Erişim Tarihi: 30.03.2013)
  11. Tullio, L.T., Karkle, E.N.L., Cândıdo, L.M. B., 2007. Review: isolation and purification of milk whey glycomacropeptide. Boletim do Centro de Pesquisa e Processamento de Alimentos 25: 121-132
  12. Yetişemeyen, A., Yıldız, F., 2008. Süt teknolojisinde kazeinomakropeptidlerin önemi ve elde edilmesi, Türkiye 10. Gıda Kongresi, Erzurum, 83-86
  13. Saito, T., Itoh, T., 1992. Variations and distributions of oglycosidically linked sugar chains in bovine kcase